US FDA approves Vera's kidney disease drug

By Siddhi Mahatole and Puyaan Singh July 7 (Reuters) - The U.S. Food and Drug Administration said on Tuesday it had approved ...

Under the Radar: Vera Stock Jumps as Kidney-Disease Drug Approved by FDA

Shares of Vera Therapeutics rose about 8% Tuesday after the Food and Drug Administration approved its treatment for a kidney ...

Kidney disease profile shifts: Diabetes-linked CKD rises as overall US rate stalls

Chronic kidney disease (CKD) is common, largely silent and serious. Most people who have the condition do not realize they ...

Vera Therapeutics wins first FDA approval with kidney disease drug

Preview this article 1 min Trutakna — a once-a-week, self-injected drug — could carry a wholesale price of nearly $400,000 a ...

VERA Stock Surges After Drug To Treat Rare Kidney Disease Gets FDA Approval – Retail Sees The Move As Catalyst For Vera Therapeutics

Vera Therapeutics' Trutakna received an early, fast-tracked approval from the FDA to reduce proteinuria in adults with ...

Vera Therapeutics Gets FDA Accelerated Approval for Trutakna in IgA Kidney Disease

Vera Therapeutics said the U.S. Food and Drug Administration granted accelerated approval for Trutakna to reduce proteinuria, or protein in urine, for adults with primary IgA nephropathy who are at ...

Finerenone helps slow kidney disease in patients without diabetes

Finerenone shows promise in slowing chronic kidney disease progression in non-diabetic patients, according to recent global ...